NEW YORK (GenomeWeb) – Thermo Fisher Scientific reported before the opening of the market on Thursday that its second quarter revenues increased 6 percent, thanks in part to large increases in laboratory products and services revenues and life sciences solutions revenues.

Separately today, Thermo Fisher said that it has signed a deal with Health BioMed to support that company's efforts to develop molecular diagnostic kits for infectious disease and pharmacogenomics screening for the Chinese market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.